CPHI
China Pharma Holdings, Inc.Company with tickers: CPHI
CIK
1106644
CUSIP
16941T401
Shares Outstanding
40,522,002
13F Activity (30d)
6 filings
6 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $1,136,287 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $1,272,348 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Gross Profit | $-136,061 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Operating Expenses | $622,557 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $29,587 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-758,618 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-785,572 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-0.24 | USD/shares | 2025-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.24 | USD/shares | 2025-03-31 | 10-Q | 2026-05-15 |